Neutrophil Counts in Healthy South African Infants: Implications for Enrollment and Adverse Event Grading in Clinical Trials in an African Setting
- PMID: 32734176
- PMCID: PMC7376988
- DOI: 10.1016/j.ympdx.2019.100005
Neutrophil Counts in Healthy South African Infants: Implications for Enrollment and Adverse Event Grading in Clinical Trials in an African Setting
Abstract
Absolute neutrophil counts are used to assess eligibility and safety during clinical trials but the toxicity grading scale used can affect enrollment and reporting of adverse events. During a trial investigating a parenteral rotavirus vaccine in South Africa, we excluded otherwise healthy infants without HIV infection from participation owing to neutropenia.
Trial registration: ClinicalTrials.gov: NCT02109484.
Keywords: DAIDS, Division of AIDS; SRC, Safety Review Committee.
© 2019 The Author(s).
Figures


Comment in
-
Laboratory testing in clinical trials: Be careful for what you ask.J Pediatr X. 2019 Aug 22;1:100007. doi: 10.1016/j.ympdx.2019.100007. eCollection 2019 Spring. J Pediatr X. 2019. PMID: 37333837 Free PMC article. No abstract available.
References
-
- Hsieh M.M., Everhart J.E., Byrd-Holt D.D., Tisdale J.F., Rodgers G.P. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med. 2007;146:486–492. - PubMed
Publication types
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous